Lifecore Biomedical to Present at Stephens Annual Investment Conference
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes,
Acadia Healthcare Company, Inc., has reached a settlement agreement with the United States Department of Justice (DOJ) to ...
ACADIA PARISH, La. (KLFY) — A 29-year-old Morse man is facing numerous charges after being accused of inappropriately ...
As a reminder, Acadia Pharmaceuticals has two primary products on the market. The first is Nuplazid, which was approved in ...
Acadia, headquartered in Franklin, Tennessee, provides behavioral healthcare services. It develops and operates acute inpatient psychiatric facilities, residential recovery facilities, eating disorder ...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
4don MSN
Law enforcement was called to Iota High School on Thursday after a loaded magazine was found on campus. After one student was ...
New York, New York-- (Newsfile Corp. - November 11, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a lawsuit against Acadia Healthcare Company, Inc. (NASDAQ ...
BANGOR, Maine (WABI) - There’s a new program in Maine to help address and advance dementia care. Northern Light Acadia ...
Zacks.com on MSN5d
Acadia's Q3 Earnings Beat, Nuplazid & Daybue Drive Revenue GrowthAcadia Pharmaceuticals ACAD reported third-quarter 2024 earnings of 20 cents per share, beating the Zacks Consensus Estimate ...
Analyst Joel Beatty of Robert W. Baird maintained a Buy rating on ACADIA Pharmaceuticals (ACAD – Research Report), with a price target of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback